Exela Appoints Kevin Lathrop as President of Exela Healthcare Solutions
Exela Technologies, Inc. (NASDAQ: XELA) has appointed Kevin Lathrop as President of Exela Healthcare Solutions, aimed at enhancing growth in its healthcare sector, which accounted for 23% of revenue in 2021. Lathrop will spearhead the healthcare business strategy and collaborate with leadership to optimize value for customers. This strategic move seeks to bolster Exela's claims processing automation and revenue cycle management services. Suresh Yannamani, President of Exela, highlighted ongoing investments to facilitate growth.
- Kevin Lathrop's appointment brings extensive experience in operational enhancements and revenue growth.
- Healthcare Solutions is critical to Exela's business, indicating potential for revenue increase.
- Concerns about the continuity of leadership experience with new appointments in key roles.
- Potential challenges in integrating new leadership perspectives with established practices.
- Exela Healthcare Solutions gearing up for growth in the healthcare sector
IRVING, Texas, March 16, 2022 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA) announced today it has hired Kevin Lathrop as President of Exela Healthcare Solutions (“HS”).
Kevin will lead Exela’s healthcare line of business and collaborate closely with leaders across the enterprise to drive Exela’s business strategy and value proposition. Kevin will be directly responsible for the growth and performance of HS.
Exela continues to invest in the healthcare segment, which is Exela’s second largest with
“These investments are part of our overall strategy to create business units for growth within our portfolio and we are already showing progress. We look forward to sharing more with customers, investors and Exelarators as we achieve new milestones,” said Suresh Yannamani, President of Exela.
“Healthcare Solutions is a significant driver of Exela’s business on multiple levels. We continue to create solutions that optimize for time and cost for payers, providers, and patients. I am excited to work with Eokesh Natarajan, Chris Spring and the rest of the Exela family to accelerate growth in a laser focused fashion for our customers to concentrate on their core business, helping patients,” said Kevin Lathrop, President of Exela HS.
Kevin brings a wealth of experience in leading large organizations and operational process enhancements from many well-known companies. Most recently, Kevin served as President and Chief Operating Officer for Transaction Data Systems where he was responsible for running the business, growing revenue and profits by double digits. Before that, Kevin was the President of TriZetto Provider Solutions, part of Cognizant, where he ran a business servicing thousands of providers. Kevin’s lengthy experience in HCIT includes multiple exits where valuation was achieved via growth and profitability.
Further, within the Exela HS organization, Chris Spring was recently hired as President of Revenue Cycle Management, and Eokesh Natarajan was promoted to President of Payer Operations.
Chris brings over 35 years of combined Health Information Management experience to Exela in domestic and international operations. During his career, Chris spent 21 years with 3M|M*Modal leading various healthcare units and RCM operations, including the launch of M*Modal’s Healthcare business in Australia. Most recently, Chris was President and COO of iMedX, Inc., a health analytics and RCM company.
Eokesh has been at Exela for over 25 years across multiple industry segments in delivery and customer relationship management in many key roles. His domain expertise and extensive payer relationships positions Exela for even further success and growth in the healthcare sector.
For more Exela news, commentary, and industry perspectives, visit: https://investors.exelatech.com/
And please follow us on social:
Twitter: https://twitter.com/exelatech
LinkedIn: https://www.linkedin.com/company/exela-technologies
Facebook: https://www.facebook.com/exelatechnologies/
Instagram: https://www.instagram.com/exelatechnologies
The information posted on the Company's website and/or via its social media accounts may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company's website and its social media accounts in addition to the Company's press releases, SEC filings and public conference calls and webcasts.
About Exela Technologies
Exela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over
Forward-Looking Statements
Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "may", "should", "would", "plan", "intend", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "continue", "future", "will", "expect", "outlook" or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation those discussed under the heading "Risk Factors" in Exela's Annual Report and other securities filings. In addition, forward-looking statements provide Exela's expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela's assessments to change. These forward-looking statements should not be relied upon as representing Exela's assessments as of any date subsequent to the date of this press release.
Investor and Media Contacts:
Vincent Kondaveeti
E: vincent.kondaveeti@exelatech.com
Mary Beth Benjamin
E: IR@exelatech.com
FAQ
What impact will Kevin Lathrop's appointment have on Exela Healthcare Solutions?
What percentage of Exela's revenue comes from the healthcare sector?
Who has been appointed to lead Exela Healthcare Solutions?
What is Exela's strategy for growth in the healthcare market?
